Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	127.44B
Revenue (ttm)	8.73B
Net Income (ttm)	2.35B
Shares Out	173.47M
EPS (ttm)	13.54
PE Ratio	54.25
Forward PE	39.51
Dividend	1.00 (0.14%)
Ex-Dividend Date	n/a

Volume	398,072
Average Volume	499,338
Open	744.00
Previous Close	734.65
Day's Range	741.00 - 778.50
52-Week Range	347.60 - 968.30
Beta	n/a
RSI	48.43
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.